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ways. In fact, since naive T cells do not express func-in naive CD4 T cells, the data presented here indicate
tional IL-12 receptor and WSX-1 ligation has been shownthat signaling through this receptor is involved in lim-
to enhance IL-12R2 expression through STAT-1-iting the intensity and duration of T cell activity. When
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naive T cells to the polarizing influences of IL-12 (Takedalar pathogen Toxoplasma gondii, they establish pro-
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This pathology was characterized by the excessive Given the importance of IL-12 and IFN- in resistance
production of IFN-, persistence of highly activated to intracellular pathogens (Trinchieri, 1998, 2003), exper-
T cells, and enhanced T cell proliferation in vivo. To- iments were performed to determine the role of IL-27/
gether, these findings demonstrate that WSX-1 is not WSX-1 in immunity to Toxoplasma gondii, an obligate
required for the generation of IFN-mediated immu- intracellular eukaryote that is an important opportunistic
nity to this parasitic infection and identify a novel func- parasite of prenatal infants and immunocompromised
tion for this receptor as a potent antagonist of T cell- adults (Denkers and Gazzinelli, 1998). Resistance to this
mediated, immune hyperactivity. pathogen is dependent on the development of a strongly
polarized, IL-12-dependent, Th1 type response that is
characterized by the production of IFN- by NK and
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al., 1994; Ely et al., 1999). The generation of protective shown). However, in contrast to WT mice, WSX-1/ mice
developed prominent immune infiltrates and necrosis inimmunity leads to control of parasite replication, but a
failure to appropriately regulate this response can lead the liver and lungs after 12 days of infection (Figures
1E–1H; data not shown). Pathology in the liver was fur-to severe T cell-mediated immune pathology typified by
the overproduction of inflammatory cytokines (Liesen- ther characterized by areas of extramedullary haema-
topoesis and a loss of hepatocytes leading to the devel-feld et al., 1996; Gazzinelli et al., 1996; Hunter et al.,
1997). opment of telangiectasia (Figure 1H). Moreover, the
spleens of infected WSX-1/ mice contained disorga-The studies presented here demonstrate that WSX-
1-deficient mice infected with T. gondii are able to devel- nized follicular structures and increased numbers of
apoptotic cells (data not shown).op a strong Th1 type response and control parasite
replication. However, infected WSX-1/ mice are unable Because previous work has associated CD4 T cells
with the development of lethal immune pathology into downregulate this protective response, and develop
a lethal, T cell-mediated inflammatory disease. This pa- experimental models of toxoplasmosis (Gazzinelli et al.,
1996; Neyer et al., 1997), studies were performed tothology was characterized by the excessive production
of IFN-, persistence of highly activated T cells, and determine if T cells mediated the acute mortality of in-
fected WSX-1/ mice. WSX-1-deficient mice were chal-enhanced T cell proliferation in vivo. The phenotype
could be recapitulated in vitro as Th1 polarization of lenged with T. gondii, treated with antibodies to deplete
CD4 or CD8 T cells, and the course of infection wasWSX-1/ CD4 T cells led to increased proliferation and
IFN- secretion. However, these studies also confirmed monitored. Although administration of CD8 on days 5,
6, and 7 postinfection did not alter the time to death ofthat, under nonpolarizing conditions, WSX-1 is required
for optimal IFN- production. Further analysis revealed infected WSX-1/ mice, the same regime using CD4
prevented early mortality (Figure 1D). Together, thesethat exogenous IL-27 can activate STAT1, STAT3, and
STAT5: STAT family members that have traditionally studies suggest that, unlike IL-12p40/ mice, the en-
hanced susceptibility of WSX-1/ mice to T. gondii isbeen associated with cellular activation but have also
recently been linked with the inhibition of immune func- not due to an inability to control parasite replication,
but rather, is a consequence of a CD4 T cell-dependenttions (O’Shea et al., 2002). Together, these findings dem-
onstrate that WSX-1 is not required for the generation immune-mediated pathology.
of IFN--mediated immunity to T. gondii and identify a
novel function for WSX-1 as a potent antagonist of T cell- Increased Cytokine Production in WSX-1/ Mice
mediated immune hyperactivity. Infected with T. gondii
To determine how the absence of WSX-1 affected the
immune response to T. gondii, a kinetic analysis wasResults
performed to monitor the production of cytokines asso-
ciated with resistance to this infection. Infection of WTWSX-1 Is Required for Resistance
to Toxoplasma gondii and WSX-1/ mice led to highly elevated serum IL-12
concentrations that were downregulated by day 11 post-To assess the role of IL-27/WSX-1 in the development
and regulation of resistance to T. gondii, studies were infection (Figure 2A). A similar profile for IL-12 produc-
tion was obtained by stimulating whole splenocytescarried out to determine whether infection resulted in
increased expression of this cytokine or its receptor. from infected mice with soluble Toxoplasma antigen
(sTAg) or CD3 (Figures 2B and 2C). Likewise, analysisWild-type C57BL/6 mice were infected with T. gondii
and RT-PCR was used to measure the levels of mRNA of TNF- and IL-23 levels in the serum revealed no signif-
icant differences between WT and WSX-1/ mice (datafor IL-27p28, EBI3, and WSX-1 in the spleen. After 7
days of infection, there was an upregulation in levels of not shown). This acute inflammatory response led to a
marked increase in systemic IFN- levels that, after 7mRNA for IL-27p28 and EBI3, while the constitutive level
of WSX-1 mRNA in unchallenged mice was not apprecia- days, was comparable between WT and WSX-1/ mice.
However, by day 11 postinfection, WT mice had down-bly altered by infection (Figure 1A). To determine the
significance of this infection-induced increase of IL-27 regulated serum levels of IFN-, whereas WSX-1/ ani-
mals still had high concentrations of circulating IFN-mRNA, WSX-1/ mice were infected with T. gondii and
their survival monitored. While WT mice were able to (Figure 2D). A similar trend was observed in splenic
recall responses from infected mice. Again, at day 0survive the acute phase of this infection, WSX-1/ ani-
mals, like IL-12p40/ mice, succumbed by day 15 (Fig- and day 7 postinfection, splenocytes from both groups
produced similar amounts of IFN-when stimulated withure 1B). Similar results were observed whether mice
were infected orally or intraperitoneally (data not shown). sTAg or CD3 (Figures 2E and 2F). At day 11 postinfec-
tion, stimulation with sTAg or CD3 induced WSX-1/Since early mortality of mice deficient in IL-12 is associ-
ated with an inability to control parasite numbers (Gazzi- splenocytes to produce remarkable levels of IFN-when
compared to WT cohorts (Figures 2E and 2F). In addition,nelli et al., 1994; Scharton-Kersten et al., 1996; Cai et
al., 2000), infected WSX-1/ mice were examined for WSX-1/ splenocytes also produced 4 times as much
IL-2 as WT T cells in these cultures (Figure 2I).signs of parasite replication. In contrast to the high para-
site burdens found in infected IL-12p40/ mice, analysis The phenotype of infected WSX-1/ mice, particularly
the overproduction of IFN- associated with lethal im-of peritoneal exudates in WT and WSX-1/ mice re-
vealed few infected cells and no obvious parasite repli- mune pathology, is similar to that of IL-10/ mice chal-
lenged with T. gondii (Figure 2J) (Gazzinelli et al., 1996;cation was present in the heart, lungs, spleen, or liver
of infected WT or WSX-1/ animals (Figure 1C; data not Neyer et al., 1997). However, as splenocytes from in-
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Figure 1. WSX-1 Is Required for Resistance
to Infection with Toxoplasma gondii
(A) Wild-type (WT) C57BL/6 mice were inocu-
lated intraperitoneally (i.p.) with 20 cysts of
the ME49 strain of T. gondii. After 7 days,
mRNA was isolated from whole splenocytes
of infected and uninfected mice. Reverse-
transcription PCR (RT-PCR) was used to as-
sess expression levels of mRNA for IL-27p28,
EBI3, WSX-1, and -actin.
(B) WT, WSX-1/, and IL-12p40/ mice were
infected with T. gondii and survival was moni-
tored (n  4 mice per group, representative
of three experiments).
(C) At 7 days postinfection, peritoneal lavage
was performed, cells were collected for cy-
tospin preparation (n  3 per group), and the
percentage of cells infected with T. gondii es-
timated.
(D) WSX-1/ mice were infected with T. gon-
dii and survival was monitored. On days 7, 8,
and 9 postinfection, mice were treated with
PBS (Ctl.), 500 g of CD4 mAB, or 500 g
CD8 mAb (n  3 per group, representative
of three experiments).
(E–H) WT and WSX-1/ animals were in-
fected for 12 days before livers were removed
and prepared for histological analysis.
fected WT and WSX-1/ mice produced similar amounts tion, a similar percentage of cells produced IFN- in
both WT and WSX-1/ animals (Figure 3A). However,of IL-10 when stimulated with sTAg or CD3 (Figures
2G and 2H), a defect in this regulatory system is unlikely by 11 days postinfection 2-fold more WSX-1/ CD4
T cells were producing IFN- when compared to WTto contribute to the acute mortality of WSX-1/ mice.
Moreover, while WSX-1/ mice are able to downregulate cohorts (85% versus 42%) (Figure 3A). Moreover, CD4
T cells from 10 day infected WSX-1/ mice producedacute, infection-induced production of IL-12, IL-10/
mice maintained high levels of this cytokine (Figure 2K). more cytokine per cell than WT cells (Figure 3A). While
WT splenocytes required ex vivo stimulation to produceThis distinction between the WSX-1/ and IL-10/ mice
suggests that the enhanced IFN- response noted in IFN-, 12.0% of CD4 T cells from WSX-1/ mice
stained positive for IFN- after 12 hr of culture in mediainfected WSX-1/ mice was not due to the failure of
IL-10 to suppress infection induced IL-12 production alone (Figure 3B). WSX-1/ Th1 cells were also able
to maintain IFN- production for longer than their WT(Figure 2L).
counterparts. When stimulated with CD3 for 72 hr, 25%
of CD4 T cells from 14 day infected WSX-1/ miceEnhanced T Cell Responses in T. gondii-Infected
WSX-1/ Mice were still secreting IFN-, while few WT IFN- producers
remained (Figure 3B).Since CD4 T cells are involved in the susceptibility of
WSX-1/ mice to acute toxoplasmosis and splenocytes To further assess how the development of the T cell
response was affected by the absence of WSX-1, recep-from infected WSX-1-deficient mice secreted elevated
levels of IFN-, single cell analysis was utilized to assess tor-deficient mice were infected with T. gondii and the
expression of various activation markers by T cells wasIFN- production by T cells. CD4 T cells from unin-
fected WT and WSX-1/ mice produced little IFN- after determined. In accord with the production of IFN-
shown in figures 2 and 3, by day 7 postinfection, a18 hr of stimulation with CD3 and at 7 days postinfec-
Immunity
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Figure 2. Cytokine Production in WSX-1/ Mice Infected with T. gondii
At 0, 7, and 11 days postinfection (X axes), serum was collected from WT and WSX-1/ mice and ELISA used to measure circulating levels
of IL-12p40 (A) or IFN- (D). At the indicated time points (X-axes), whole splenocytes from WT and WSX-1/ mice were cultured with soluble
Toxoplasma antigen (sTAg, 25 g/ml) or plate bound CD3 antibody (1 g/ml) for 72 hr and assayed for IL-12p40 (B and C), IFN- (E and F),
IL-10 (G and H) and IL-2 (I) production (n  3 mice per group, representative of three separate experiments). WT, WSX-1/, and IL-10/
mice were infected with T. gondii and survival was monitored. (n  3 mice per group) (J). At 0 (uninfected) and 10 days postinfection, whole
splenocytes from WT, WSX-1/, and IL-10/ mice were cultured with sTAg for 72 hr and concentrations of IL-12p40 (K) and IFN- (L) were
measured by ELISA.
comparable rise in the number of activated T cells general downregulation of the anti-Toxoplasma re-
sponse, the frequency of CD25high/CD62Llow CD4 T cells(CD25high/CD62Llow) was observed in WT and WSX-1/
mice (Figure 4A). While the number of activated T cells in WSX-1/ mice increased further (Figure 4A). A similar
profile for the production of IFN- and expression ofin WT mice was decreased after 10 days of infection,
consistent with decreased production of IFN- and a activation markers was observed for CD8 T cells from
WSX-1 Suppresses T Cell Responses during Infection
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Figure 3. Enhanced Production of IFN- by
CD4 T Cells from WSX-1/ Mice Infected
with T. gondii
(A) Splenocytes from WT and WSX-1/ mice
infected for 0, 7, and 10 days were isolated
and stimulated with plate bound CD3 anti-
body for 18 hr before staining for CD4 and
intracellular IFN-.
(B) Splenocytes were isolated from WT and
WSX-1/ mice that were infected with T.
gondii for 11 days. Cells were either rested
in media for 12 hr or stimulated with CD3
antibody for 72 hr, before staining for CD4
and intracellular IFN-. For flow cytometry,
only CD4 events are displayed and rectan-
gular gates indicate specific IFN- staining
compared to control mAb; the percentage of
IFN- cells are oriented horizontally while
mean fluorescence intensity (MFI) values are
oriented vertically.
infected WSX-1/ mice (see Supplemental Figure S1 at the accumulation of pathogenic CD4 T cells occurring
during acute T. gondii infection of WSX-1/ mice. To-http://www.immunity.com/cgi/content/full/19/5/645/
DC1). gether, these studies indicate that while WSX-1 is not
necessary for the generation of highly activated Th1Although there were elevated numbers of activated
T cells in WSX-1/ mice infected with T. gondii, the basis effector T cells following challenge with T. gondii, this
receptor is required to regulate the intensity and dura-of this accumulation remained unclear. Since previous
reports have shown that WSX-1/ CD4 T cells have tion of infection induced Th1 responses.
enhanced proliferative responses in vitro (Chen et al.,
2000; Yoshida et al., 2001), studies were performed to WSX-1/ T Cells Exhibit Intrinsic Hyperactivity
after Infection with T. gondiievaluate in vivo proliferation of WSX-1/ T cells. WT
and WSX-1/ mice were infected with T. gondii, treated Although infection with T. gondii led to an expanded
population of activated Th1 cells in WSX-1/ mice, itwith BrdU and, at different times postinfection, the incor-
poration of this synthetic nucleotide was determined was unknown whether this enhanced persistence was
cell autonomous or mediated through altered accessoryin CD4 T cells. Again, as with IFN- production and
activation marker expression, the amount of BrdU incor- cell function. To address this issue, RAG-2/ mice were
reconstituted with WT or WSX-1/ lymphocytes andporated was comparable between WT and WSX-1/
CD4 lymphocytes at days 0 and 10 postinfection (Fig- then infected with T. gondii for 11 days. Analysis of T cell
responses in these reconstituted mice revealed that, asure 4B). After 2 weeks, suppression of the WT immune
response was reflected in decreased numbers of CD4 in infected WSX-1/ mice, adoptively transferred
WSX-1/ T cells produced elevated levels of IFN- dur-T cells that had incorporated BrdU. In contrast, at this
later time point, the population of WSX-1/ CD4 T cells ing recall responses (Figure 5A). Furthermore, WSX-1/
CD4 T cells were 3 times more likely to produce IFN-that had incorporated BrdU continued to expand (Figure
4B). This enhanced proliferative response, a phenome- (67% versus 20%) and had increased expression of acti-
vation markers when compared to WT cohorts (Figuresnon previously reported in vitro, is likely to contribute to
Immunity
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Figure 4. Increased Activation and In Vivo
Proliferation of WSX-1/ CD4 T Cells after
Infection with T. gondii
(A) WT and WSX-1/ mice were infected for
0, 7, and 10 days before splenocytes were
isolated and stained for expression of CD4,
CD25, and CD62L directly ex vivo. Numbers
represent the percentage of CD4 cells in
each indicated quadrant with the percentage
of CD25high/CD62Llow in bold type.
(B) WT and WSX-1/ mice were infected
orally with T. gondii and treated with BrdU
for 3 days prior to sacrifice at days 0, 10, and
14 postinfection. Lymphocytes were isolated
from mesenteric lymph nodes and stained for
CD4 expression and incorporation of BrdU
directly ex vivo. Rectangular gates represent
specific BrdU staining compared to control
mAb.
5B and 5C). These data indicate that the hyperactivity with previous studies, IL-27/WSX-1 is crucial for the
optimal production of IFN- by naive CD4 T cells thatthat follows infection is intrinsic to the T cells and not
due to defects in the accessory cell compartment of have been activated under nonpolar conditions. How-
ever, a role for IL-27/WSX-1 in the regulation of otherWSX-1/ mice.
effector functions was suggested by a small but repro-
ducible increase in the ability of WSX-1/ CD4 T cellsWSX-1 Is Not Required for In Vitro Th1 Differentiation
In contrast to the data presented above, previous re- to proliferate (Figure 6A).
When naive WT and WSX-1/ CD4 T cells were dif-ports suggested that IL-27/WSX-1 is required for opti-
mal Th1 differentiation (Chen et al., 2000; Yoshida et al., ferentiated under Th1 polarizing (rIL-12, IL-4), there
was no significant difference in the percentage of WT2001; Pflanz et al., 2002). Therefore, in vitro studies were
performed to further assess the impact of WSX-1 defi- and WSX-1/ cells that produced IFN- (Figure 6B).
However, analysis of supernatants from the same cul-ciency on CD4 T cell responses. RT-PCR analysis re-
vealed increased expression of IL-27p28 and EBI3 tures revealed that WSX1/ CD4 T cells secreted 2
to 3 times more IFN- than WT cohorts (Figure 6B).mRNA in all cultures, indicating the likely presence of
IL-27 in these studies (data not shown). When naive, Moreover, a marked increase in proliferation was also
noted in CD4 T cells from the WSX-1/ cultures (FigureWT CD4 T cells were activated under nonpolarizing
conditions (IL-4, IL-12), a small percentage of WT 6B). These data indicate that, when activated under Th1
conditions, a similar frequency of IFN- WT andcells became competent to produce IFN- and a low
concentration of protein was detected in the superna- WSX-1/ T cells arise, but due to enhanced proliferation,
more total WSX-1-deficient IFN- cells accumulatetants (Figure 6A). In parallel cultures, a reduced percent-
age of WSX1/ CD4 T cells stained positive for IFN- thereby leading to a significant increase in the secreted
protein concentrations. Thus, in the presence of stronglywhile almost no IFN-was secreted (Figure 6A). By using
CFSE labeling to track cell divisions, a small but repro- polarizing IL-12 concentrations in vitro or during in vivo
infection with T. gondii, the ability of IL-27/WSX-1 toducible increase in the ability of WSX-1/CD4 T cells
to proliferate was noted (Figure 6A). Thus, in accord augment IFN- production becomes redundant. Fur-
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recombinant IL-27 could enhance CD4 T cell IFN-
responses (Pflanz et al., 2002). Therefore, to explore the
basis for the stimulatory and inhibitory effects of IL-27/
WSX-1 on T cell function, naive CD45RBHi CD4 T cells
were treated with rIL-27 in vitro and the signaling path-
ways activated by this cytokine were examined. Based
on structural homology of WSX-1 with other class I cyto-
kine receptors (Sprecher et al., 1998; Pflanz et al., 2002),
it was likely that IL-27 would activate the Jak/STAT sig-
naling pathway. Cells were stimulated with various cyto-
kines and the ability to phosphorylate STATs 1, 3, and
5 was assessed. Stimulation of naive CD4 T cells with
IL-2 or IL-12 failed to activate STAT1, STAT3, or STAT5
(data not shown), while exogenous IFN- and IFN- re-
sulted in activation of STAT1 and STAT3 but not STAT5.
In contrast, stimulation with IL-27 led to increased tyro-
sine phosphorylation of STAT1, STAT3, and STAT5 (Fig-
ure 7). These data are in accord with recent reports
that WSX-1 signaling leads to STAT-1 phosphorylation
(Hibbert et al., 2003; Takeda et al., 2003), but the finding
that IL-27 can also activate STAT3 and STAT5 in naive
CD4 T cells extends our knowledge of the signaling
pathways used by IL-27/WSX-1.
Discussion
Based primarily on in vitro studies that showed the IL-27/
WSX-1 receptor-ligand interaction could enhance IFN-
production, a consensus emerged that WSX-1 was an
Figure 5. WSX-1/ CD4 T Cells Have an Intrinsic Defect in the essential receptor for the development of Th1 type re-
Regulation of Effector Functions sponses (Robinson and O’Garra, 2002; Ho and Glimcher,
(A) Splenocytes were isolated from uninfected mice, depleted of 2002; Murphy and Reiner, 2002; Agnello et al., 2003).
adherent cells, and 75  106 WT or WSX-1/ cells were adoptively However, the present studies demonstrate that under
transferred into RAG-2/mice. Seven days later, mice were infected the strongly Th1 polarizing conditions that occur during
with T. gondii and at 11 days postinfection, whole splenocytes from
toxoplasmosis or in vitro culture, WSX-1 is not requiredWT and WSX-1/ mice were cultured with soluble Toxoplasma
for the development of Th1 effector cells. In fact, infec-antigen or plate bound CD3 antibody for 72 hr and assayed for
IFN- production by ELISA (ng/ml). tion of WSX-1-deficient mice with T. gondii revealed a
(B) At 11 days postinfection, splenocytes were isolated, cultured regulatory role for this receptor. WSX-1/ animals ex-
with plate bound CD3 antibody (1g/ml) for 18 hr, and then stained hibit prolonged IFN- responses and an accumulation of
for CD4 and intracellular IFN-. highly activated T cells that is associated with increased
(C) At day 11 postinfection, splenocytes were isolated and stained
T cell proliferation.for expression of CD4, CD25, and CD62L directly ex vivo. Numbers
It is well established that antigen dose and cytokinerepresent the percentage of CD4 cells in each indicated quadrant
with the percentage of CD25high/CD62Llow in bold type. environment are critical factors in the differentiation of
naive CD4 T cells into effector Th1 and Th2 cells (Mur-
phy and Reiner, 2002; Trinchieri, 2003). Moreover, T cells
thermore, these data suggest that, while IL-27/WSX-1 must proliferate, not only to acquire effector functions,
plays an important role in the regulation of several ef- but also to curb activation and thereby limit the duration
fector functions, like proliferation and cytokine produc- and intensity of an immune response (Doyle et al., 2001).
tion, WSX-1-deficient CD4 T cells do not have an intrin- Because the role of IL-27/WSX-1 in T cell differentiation
sic defect in Th1 differentiation. was previously assessed using ConA in combination
with polarizing cytokines, it is possible that the en-
hanced proliferation of these cells led to abbreviatedIL-27 Signaling Leads to Heterogeneous
STAT Activation cytokine production, which could then be interpreted
as a defect in Th1 differentiation. The data presentedThe data presented above demonstrate that both WT
and WSX-1/ mice develop a vigorous, protective Th1 here show that when T cells are activated through TCR
ligation and in highly polarizing conditions, there is antype response following infection with T. gondii, but while
WT mice can downregulate this response, WSX-1/ mice important role for IL-27/WSX-1 as a negative regulator
of Th1 type responses. These finding are consistent withare unable to do so. Furthermore, the failure to downreg-
ulate CD4 T cell responses contributes to the infection- a recent report in which CD4 T cells from mice lacking
the EBI3 component of IL-27 produced significantlyinduced mortality in WSX-1/ mice. While these studies
provide a cellular mechanism for the severe immune more IFN- than their wild-type counterparts in vitro
(Nieuwehuis et al., 2002). While it is clear that WSX-1/pathology observed in WSX-1/ mice (Figure 1H), they
are inconsistent with previous studies that showed that CD4 T cells do not have an intrinsic defect in their
Immunity
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Figure 6. WSX-1 Is Not Required for In Vitro Th1 Differentiation
Naive CD4 T cells were purified from uninfected WT or WSX-1/ spleens, stained with CFSE, and activated with soluble CD3 (0.1 g/ml)
and CD28 (0.5 g/ml) under either (A) nonpolarizing conditions (-IL-12 and -IL-4) or (B) Th1 polarizing conditions (rIL-12 plus -IL-4). First,
after 72 hr of culture, supernatants were collected and secreted levels of IFN- determined by ELISA. Then, remaining cells from the same
cultures were stimulated with PMA and ionomycin for 4 hr before performing intracellular staining for IFN- in combination with CFSE and
CD4. Based on CFSE profiles, the number of cells in each individual generation was calculated and data are presented in each table for WT
and WSX-1/ T cells under neutral (A) and Th1 (B) polarizing conditions.
ability to become Th1 effector cells, it has been reported During infection, the ability to downregulate T cell
responses after pathogen control is a critical functionthat recombinant IL-27 can synergize with IL-12 to en-
hance IFN- production by naive T cells and NK cells of an appropriate immune response, but little is known
about the mechanisms that mediate this process. In(Pflanz et al., 2002), Therefore, the ability of IL-27 to
activate STAT-1 and thereby induce expression of T-bet the above studies, STAT4 phosphorylation could not be
detected after treatment of naive cells with either IL-(Lighvani et al., 2001; Afkarian et al., 2002), a key tran-
scription factor in Th1 differentiation, may be crucial 12 or IL-27 (data not shown). Though the absence of
functional IL-12R on the surface of naive CD4 T cellsfor maximal Th1 differentiation when concentrations of
polarizing cytokine are limiting (Figure 6A). However, explains the relative inactivity of IL-12 in this assay, a
recent report on WSX-1 signaling in naive human lym-in the context of high IL-12 concentrations, like those
induced by acute toxoplasmosis, there is no require- phocytes suggests that despite functional receptor ex-
pression, IL-27 fails to activate STAT4 (Hibbert et al.,ment for IL-27-induced expression of T-bet, thus con-
firming a central role for IL-12, and not IL-27, in the 2003). Furthermore, this finding is consistent with previ-
ous studies that indicate that exogenous IL-27 does notdevelopment of IFN- responses that are essential for
control of T. gondii. lead to STAT4 phosphorylation in WSX-1 transfected
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respond to growth and survival stimuli (Nakagawa et al.,
2002). Although SOCS1-deficient mice spontaneously
develop severe liver pathology similar that of WSX-1/
mice infected with T. gondii (Alexander et al., 1999),
initial studies have not revealed decreased, in vitro ex-
pression of SOCS1 by WSX-1/ T cells (data not shown).
A role for WSX-1 in the downregulation of T cell re-
sponses does not appear to be restricted to toxoplas-
mosis as infection of WSX-1/ mice with Trypanosoma
cruzi also resulted in the development of immune pathol-
ogy (Hamano et al., 2003). Other studies from this labora-
tory have also found that when WSX-1/ mice were
infected with the intestinal helminth Trichuris muris, they
developed an exaggerated Th2 response that was asso-
ciated with enhanced expulsion of the parasite (unpub-
lished data). Consequently, the previous report of in-
creased susceptibility of WSX-1/ mice to L. major
(Yoshida et al., 2001) cannot simply be attributed to
a failure in the generation of Th1 responses. Because
resistant mouse strains produce an acute Th2 response
when challenged with L. major (Stetson et al., 2002),
an inability to regulate this acute IL-4 production, in
combination with the absence of WSX-1-dependent
STAT-1 activation, could inhibit initial generation of pro-
tective Th1 type cells and thereby delay disease resolu-
tion in WSX-1/ mice (Yoshida et al., 2001). In supportFigure 7. Exogenous IL-27 Leads to Activation of STAT-1, STAT-3,
and STAT-5 of this hypothesis, in vivo neutralization of IL-4 was
Naive CD4CD45RBhi T cells were sorted from WT spleens, rested found to restore the ability of WSX-1/ mice to control
overnight, and then stimulated with rIFN-, IFN-, or rIL-27 (all 50 L. major and, in these experiments, WSX-1/ T cells
ng/ml) for 15 min. Cells were then lysed and total or tyrosine phos- were found to produce more IFN- than those of similarly
phorylated STAT-1, STAT-3, and STAT-5 were detected by West-
treated WT mice (P. Scott and C.A.H., unpublished data).ern blot.
Together, these studies indicate that one role of WSX-1
is to control the kinetics, but not polarity, of an immune
response and that signaling through this receptor maymurine cell lines (Takeda et al., 20003). Nevertheless,
act as a general negative regulator of infection-inducedthe recognition that WSX-1 can activate STAT1, STAT3,
T cell effector functions. Consequently, the identificationand STAT5 does provide an insight into the pathways
of a role for WSX-1 in the suppression of T cell hyperac-that are involved in the negative regulation of T cell
tivity has obvious clinical implications for T cell-medi-responses. While tyrosine phosphorylation of these
ated inflammatory disorders and represents a novel tar-STAT family members has been previously associated
get for immune based therapies.with the activation of immune cells, it is becoming clear
that they also have a crucial role in preventing immune
Experimental Procedureshyperactivity (O’Shea et al., 2002). Cytokines like IFN-,
IFN-/, and IL-6 activate similar STAT pathways and Experimental Animals
can have profound suppressive effects on immune re- Four- to six-week-old WT, C57B/6 mice were purchased from Ta-
conic farms. WSX-1/ mice were provided by Dr. Christiaan Sarissponses (Dalton et al., 1993; Nguyen et al., 2000; Diehl
(Amgen) and bred in-house at the University of Pennsylvania. Four-et al., 2000; Chu et al., 2000; Dalton et al., 2000). Although
to six-week-old IL-12p40/ and RAG-2/ mice were purchasedlittle is known about the molecular mechanisms govern-
from Jackson Laboratories and IL-10/ mice were bred in-houseing these inhibitory processes, several studies have
at the University of Pennsylvania. All animals were maintained under
shown that STAT1 is a negative regulator of proliferation specific pathogen free conditions, in accordance to institutional
and IFN- production by Th1 cells (Cousens et al., 1997; guidelines.
Nguyen et al., 2000; Lee et al., 2000). Additionally, abla-
Toxoplasma gondii Infectionstion of STAT3 in bone marrow haematopoetic progeni-
The ME49 strain of T. gondii was maintained in Swiss Webster andtors led to the development of immune-mediated colitis
CBA/CaJ mice. ME49 bradyzoite cysts were prepared from donorin mice, while germline deletion of the STAT3 isoform
mice as described previously (Cai et al., 2000). Mice were challenged
results in impaired recovery from LPS-induced shock with 20 T. gondii cysts either by i.p. or oral administration. Through-
(Welte et al., 2003; Yoo et al., 2002). Thus, the absence out the manuscript, all infections were performed i.p. unless other-
wise noted. To assess parasite burden, mice were infected i.p. withof IL-27-mediated STAT activation could provide a mo-
T. gondii and, after 7 days, peritoneal lavage was performed. Cellslecular mechanism for the T cell hyperactivity observed
were collected for cytospin preparation and the number of infectedin WSX-1/ mice that have been infected with T. gondii.
cells estimated by microscopy (n 3 per group and at least 500 cellsHowever, it is still uncertain whether WSX-1- dependent
counted per mouse) (Cai et al., 2000). For histological examinations,
STAT activation can directly inhibit T cell responses or lungs, heart, spleen, and liver were collected from animals that were
operates through other trans factors, such as SOCS infected with T. gondii for 0 (uninfected) or 12 days. Organs were
fixed in 10% formalin, embedded in paraffin, sectioned, and stainedfamily members to limit the ability of effector T cells to
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with hematoxylin and eosin. For in vivo depletion of T cells, WSX-1/ In Vitro Signaling Assays
Naive CD4CD45RBhi T cells were purified from WT spleens by FACSmice were treated with the indicated antibody at days 7, 8, and 9
postinfection. Endotoxin free CD4 (GK1.5) and CD8 (H35-17.2) sorting (Pflanz et al., 2002). Cells were rested in media overnight
and then stimulated with recombinant cytokines for 15 min. Cyto-mAbs were grown from hybridomas.
kines used were IL-2, 50 ng/ml (R&D Systems); IL-12, 200 ng/ml
(R&D Systems); IFN-, 50 ng/ml (R&D Systems); IFN-, 50 ng/ml
Detection of IL-27/WSX-1 mRNA Levels
(R&D Systems); IL-27, 50 ng/ml (DNAX, in-house hyperkines). After
For ex vivo analysis of mRNA expression, whole splenocytes were
stimulation, cells were lysed and probed for total and tyrosine phos-
isolated from WT mice that had been infected for 0 (uninfected) and
phorylated STAT proteins by Western blot (Hibbert et al., 2003). All
7 days. After using standard procedures to isolate of mRNA (Mullen
phospho-STAT antibodies from NEB (Cell Signaling Technology),
et al., 2001), PCR (34 cycles: 95	C 30 s./60	C 30 s./72	C 1 min.) was
STAT-1 from Transduction Labs, STAT-3, STAT-4, and STAT-5 from
utilized to quantify message levels. -actin expression was used as
Santa Cruz.
an internal control to assure equal loading of every reaction. Primers
used were: IL-27p28: 5
-CTGGTACAAGCTGGTTCCTG, 5
-CTCC
AcknowledgmentsAGGGAGTGAAGGAGCT; EBI3: 5
-CAGAGTGCAATGCCATGCTTC
TC3
, 5
-CTGTGAGGTCCTGAGCTGAC; WSX-1: 5
-CAAGAAGAG
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